Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
PURPOSE To determine whether the addition of pemetrexed to gefitinib (P+G) provides clinical benefit, compared with gefitinib monotherapy, in patients with advanced nonsquamous (NS) non-small-cell… Continue Reading
1544 Background: The association between human papillomavirus (HPV) and cervical cancer is well known. However, it remains unclear whether there is also a correlation between HPV infection and human… Continue Reading
The GioTag study aimed to assess outcomes in real-world patients who received first-line afatinib followed by osimertinb.
Background: Immune checkpoint-based therapy has revolutionized the care of patients with NSCLC. Pembrolizumab-based combination therapy aims to improve clinical outcomes over pembrolizumab… Continue Reading
BackgroundMET amplification (amp) is a resistance mechanism to EGFR tyrosine kinase inhibitors (TKIs). Tepotinib (TEP), an oral, selective MET TKI, has shown promising antitumor activity in… Continue Reading
Background: Reirradiation is increasingly used to treat recurrent pediatric brain tumors, but data-driven dose-volume constraints for repeat radiation are lacking. Methods: Records of 12 pediatric… Continue Reading
IRB# 11851 GO29437: A Phase III, Open-Label, Multicenter, Randomized Study Evaluating The Efficacy And Safety Of Atezolizumab (Anti−PdL1 Antibody) In Combination With Carboplatin+Paclitaxel Or… Continue Reading